{
    "type": "ETP",
    "ucits": false,
    "leverage": true,
    "derivatives": true,
    "swaps": true,
    "inverse": false,
    "replication_method": "synthetic",
    "complex_factors": [
        "Leverage 3x exposure",
        "Synthetic replication via derivatives",
        "Daily leverage rebalancing and compounding effects",
        "Counterparty and collateral risk",
        "Opaque payoff structure",
        "High risk class (6/7)",
        "No capital protection",
        "Complex underlying reference (leveraged exposure to iShares MSCI Japan ETF)",
        "Potential for significant losses amplified by leverage",
        "Short recommended holding period (1 day) due to complexity"
    ],
    "classification": "complex",
    "supporting_data": "The product is a 3x leveraged Exchange Traded Product (ETP) that seeks to deliver three times the daily performance of the iShares MSCI Japan ETF. It uses derivatives (swaps) to synthetically replicate this exposure, which introduces counterparty and collateral risks that are difficult for retail investors to understand. The leverage is significant (3x), and the product employs daily rebalancing, causing compounding effects that can lead to returns diverging substantially from the underlying index over longer holding periods. The product is non-UCITS and collateralised, with no capital protection, and is classified as high risk (6 out of 7). The complexity arises from the synthetic replication method, embedded derivatives, leverage, and the need for sophisticated understanding of risks such as counterparty risk, compounding, and volatility impact. According to MiFID II Article 25(4)(a)(vi) and Article 57 of the Delegated Regulation, such features render the product complex, requiring an appropriateness assessment before sale to retail clients. This aligns with ESMA guidance that synthetic ETFs and leveraged products are complex due to their structure and risk profile. Therefore, this ETP must be classified as complex under MiFID II."
}